T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Ball Corp
BALL
$16.4B
| $24.1M | ﹤0.01% |
462,896
-2,467,915
| -84% | -$130M |
|
902
Mueller Industries
MLI
$14.7B
| $24.1M | ﹤0.01% |
632,928
+11,280
| +2% | +$450K |
|
903
SLM Corp
SLM
$5.22B
| $24.1M | ﹤0.01% |
819,306
-11,702
| -1% | -$342K |
|
|
EFOR
904
Everforth Inc
EFOR
$1.37B
| $24M | ﹤0.01% |
381,565
+12,757
| +3% | +$982K |
|
|
PRMB
905
Primo Brands
PRMB
$8.97B
| $24M | ﹤0.01% |
676,960
+331,222
| +96% | +$10.8M |
|
906
LeMaitre Vascular
LMAT
$1.87B
| $24M | ﹤0.01% |
285,735
+956
| +0.3% | +$88.9K |
|
907
PTC Therapeutics
PTCT
$6.01B
| $23.9M | ﹤0.01% |
468,554
-40,650
| -8% | -$2.03M |
|
908
Akamai
AKAM
$18B
| $23.8M | ﹤0.01% |
296,033
+1,224
| +0.4% | +$110K |
|
909
Trimble
TRMB
$13.4B
| $23.8M | ﹤0.01% |
362,331
+8,686
| +2% | +$624K |
|
|
CPRX
910
DELISTED
Catalyst Pharmaceutical
CPRX
| $23.7M | ﹤0.01% |
977,623
-237,815
| -20% | -$5.36M |
|
911
Coherent
COHR
$64B
| $23.6M | ﹤0.01% |
362,776
-146,339
| -29% | -$12.1M |
|
912
Alliant Energy
LNT
$18.2B
| $23.5M | ﹤0.01% |
365,584
+5,236
| +1% | +$320K |
|
|
BCAX
913
Bicara Therapeutics
BCAX
$1.56B
| $23.4M | ﹤0.01% |
1,798,021
+250,841
| +16% | +$3.33M |
|
914
Kohl's
KSS
$2.22B
| $23.4M | ﹤0.01% |
2,855,659
-2,058,471
| -42% | -$23.9M |
|
915
Valvoline
VVV
$4.31B
| $23.3M | ﹤0.01% |
669,961
-19,765
| -3% | -$721K |
|
916
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $23.3M | ﹤0.01% |
+45,777
| New | +$2.32M |
|
917
Evertec
EVTC
$1.91B
| $23.2M | ﹤0.01% |
631,877
+4,056
| +0.6% | +$140K |
|
|
HOLX
918
DELISTED
Hologic
HOLX
| $23M | ﹤0.01% |
373,091
-856,764
| -70% | -$56.8M |
|
919
Dycom Industries
DY
$12.3B
| $22.9M | ﹤0.01% |
150,435
+1,556
| +1% | +$268K |
|
920
Viridian Therapeutics
VRDN
$2.49B
| $22.8M | ﹤0.01% |
1,688,129
+361,318
| +27% | +$6.15M |
|
921
Synaptics
SYNA
$4.2B
| $22.7M | ﹤0.01% |
356,315
+328,037
| +1,160% | +$23.8M |
|
922
Haemonetics
HAE
$4.11B
| $22.7M | ﹤0.01% |
357,182
+2,901
| +0.8% | +$197K |
|
923
Addus HomeCare
ADUS
$2.2B
| $22.5M | ﹤0.01% |
227,058
+422
| +0.2% | +$46.9K |
|
924
UMB Financial
UMBF
$11.5B
| $22.3M | ﹤0.01% |
220,939
+65,806
| +42% | +$7.26M |
|
925
Travel + Leisure Co
TNL
$4.58B
| $22.3M | ﹤0.01% |
482,235
+26,744
| +6% | +$1.4M |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.